Last updated on 26 Jan 2023
Owner Info
Global Blood Therapeutics, Inc.
181 Oyster Point Boulevard
South San Francisco CA 94080, UNITED STATES OF AMERICA
Serial Number
2300433 filed on 15 Aug 2022
Correspondent
BOMHARD IP, S.L.
C/ Bilbao, 1, 5°,
E-03001 ALICANTE,
SPAIN
2300433
15 Aug 2022
15 Aug 2032
WORD
22 Apr 2022
US
Status Date | Action Taken |
---|---|
26th Jan 2023 | Amendment to International Registration Contact Requested |
1st Dec 2022 | International Registration in Australia Protected correspondence sent |
30th Nov 2022 | IP Right Registration Published |
30th Nov 2022 | Status change to Registered/Protected |
23rd Sept 2022 | Application Accepted correspondence sent |
23rd Sept 2022 | IP Right has been Examined |
23rd Sept 2022 | IP Right Acceptance Published |
21st Sept 2022 | Status change to Accepted |
19th Sept 2022 | Awaiting examination |
19th Sept 2022 | Examination expedited |